30
Participants
Start Date
October 10, 2017
Primary Completion Date
April 16, 2019
Study Completion Date
June 21, 2019
LY03003 ( Rotigotine, extended-release microspheres)
"Patients to be enrolled to 70 mg dose group will receive 14 mg in the first week, 28 mg in the second week, 42 mg in the third week,56 mg in the fourth week and then 70 mg in the next 5 weeks.~Patients to be enrolled to 84 mg dose group will receive 14 mg in the first week, 28 mg in the second week, 42 mg in the third week,56 mg in the fourth week, 70mg in the fifth week and then 84 mg in the next 5 weeks."
Placebo, extended-release microspheres
"Patients to be enrolled to 70 mg dose group will receive 14 mg in the first week, 28 mg in the second week, 42 mg in the third week,56 mg in the fourth week and then 70 mg in the next 5 weeks.~Patients to be enrolled to 84 mg dose group will receive 14 mg in the first week, 28 mg in the second week, 42 mg in the third week,56 mg in the fourth week, 70mg in the fifth week and then 84 mg in the next 5 weeks."
Chinese PLA General Hospital, Beijing
Xuanwu Hospital Capital Medical University, Beijing
Shengjing Hospital of China Medical University, Shenyang
Beijing Bozhiyin T&S Co., Ltd.
INDUSTRY
Luye Pharma Group Ltd.
INDUSTRY